Review Article
Direct Oral Anticoagulants in Cirrhotic Patients: Current Evidence and Clinical Observations
Table 1
Route of elimination of DOACSs.
| DOAC | Liver elimination | Renal elimination |
| Apixaban | 75% | 25% | Rivaroxaban | 65% | 35% | Edoxaban | 50% | 50% | Dabigatran | 20% | 80% |
|
|